drugset / Trial / NCT01951508

Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study

NCT01951508

Phase 0 Completed 24 enrolled University Hospital, Basel, Switzerland
CrossoverQuadruple-blindBasic science

Summary

The purpose of this study is to investigate effects of methylphenidate, modafinil, and 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") on emotion-processing and cognitive performance using functional magnetic resonance imaging (fMRI) techniques. The primary hypothesis is that these psychostimulants differentially affect processing of emotional stimuli and potentially leading to alterations in social cognition and behavior.

Timeline

Start
2013-10
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 3,4-Methylenedioxymethamphetamine Unknown 125 mg Oral
Subject Methylphenidate Small molecule 60 mg Oral
Subject Modafinil Small molecule 600 mg Oral